Correlation Between Serum Level of PCⅢ and the Degree of Hepatic Fibrosis in Patients with Chronic Liver Diseases

Wang Xue,Xu Yu,Li Wenjie

DOI: https://doi.org/10.3969/j.issn.1008-9810.2007.03.002

2007-01-01

Abstract:Objective To study the correlation between serum level of PCⅢ and the degree of liver fibrosis in patients with chronic liver diseases. Methods Serum level of PCⅢ was assayed with RIA and other markers of liver function (including ALT, AST, STB, SDB, TP, ALB, TBA) were assayed with automatic biochemical analyzer in 188 patients with various chronic liver drseases. PCⅢ only were examined in 70 controls. Results ① The serum levels of PCⅢ were in this order: chronic severe hepatitis (n=27,501.17±191.09)>liver cirrhosis from chronic hepatitis(n=27,334.52±139.14)>chronic moderate hepatitis (n=32,298.02±151.02)>primary liver cancer (n=39,281.42±143.48)>normal controls (n=70,122.56±92.94). ② The serum levels of PCⅢ were positively correlated with STB and SDB levels (P<0.05) in patients with chronic severe hepatitis and was significantly positively correlated with ALP levels (P<0.01). ③ The serum level of PCⅢ were significantly positively correlated with STB, SDB, TBA and ALP in patients with cirrhosis from chronic hepatitis (P<0.01). ④ The serum levels of PCⅢ were significantly positively correlated with AST and ALP levels in patients with chronic moderate hepatitis (P<0.01). ⑤ The serum levels of PCⅢ were significantly positively correlated with STB, SDB, TBA, AST and ALP in patients with primary liver cancer (P<0.01). Conclusion Serum level of PCⅢ might adequately reflect the activity of the process of hepatic fibrosis, but did not necessarily reflect the degree of fibrosis already attained.